CASI Pharmaceuticals delisted from Nasdaq for failure to meet continued-listing standards
CASI Pharmaceuticals, Inc. was removed from listing on the Nasdaq Stock Market.
Company
SEC filing news and material events for CASI Pharmaceuticals, Inc., briefed from primary-source filings.
1 story
CASI Pharmaceuticals, Inc. was removed from listing on the Nasdaq Stock Market.